Stocks or ETFs side by side: scores, returns, risk, valuation and what they hold.
| Measure | AZNAstraZeneca PLC | NVSNovartis AG |
|---|---|---|
| Sector | Healthcare | Healthcare |
| Industry | Drug Manufacturers - General | Drug Manufacturers - General |
| Country | United Kingdom | Switzerland |
| Market cap | $290B | $308B |
| Price | $186.76 | $163.26 |
| Last day | −1.39% | −0.26% |
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines.
AZN analysis and Q-Scores →Novartis AG researches, develops, manufactures, distributes, markets, and sells pharmaceutical medicines in Switzerland and internationally.
NVS analysis and Q-Scores →Data as of 2026-10-13. Not investment advice.